Literature DB >> 11891069

Studies on the development of oral colon targeted drug delivery systems for metronidazole in the treatment of amoebiasis.

Y S R Krishnaiah1, P R Bhaskar Reddy, V Satyanarayana, R S Karthikeyan.   

Abstract

The aim of the present study is to develop colon targeted drug delivery systems for metronidazole using guar gum as a carrier. Matrix, multilayer and compression coated tablets of metronidazole containing various proportions of guar gum were prepared. All the formulations were evaluated for the hardness, drug content uniformity, and were subjected to in vitro drug release studies. The amount of metronidazole released from tablets at different time intervals was estimated by high performance liquid chromatography method. Matrix tablets and multilayer tablets of metronidazole released 43-52% and 25-44% of the metronidazole, respectively, in the physiological environment of stomach and small intestine depending on the proportion of guar gum used in the formulation. Both the formulations failed to control the drug release within 5 h of the dissolution study in the physiological environment of stomach and small intestine. The compression coated formulations released less than 1% of metronidazole in the physiological environment of stomach and small intestine. When the dissolution study was continued in simulated colonic fluids, the compression coated tablet with 275 mg of guar gum coat released another 61% of metronidazole after degradation by colonic bacteria at the end of 24 h of the dissolution study. The compression coated tablets with 350 and 435 mg of guar gum coat released about 45 and 20% of metronidazole, respectively, in simulated colonic fluids indicating the susceptibility of the guar gum formulations to the rat caecal contents. The results of the study show that compression coated metronidazole tablets with either 275 or 350 mg of guar gum coat is most likely to provide targeting of metronidazole for local action in the colon owing to its minimal release of the drug in the first 5 h. The metronidazole compression coated tablets showed no change either in physical appearance, drug content or in dissolution pattern after storage at 40 degrees C/75% RH for 6 months.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891069     DOI: 10.1016/s0378-5173(02)00006-6

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  13 in total

1.  In vivo evaluation of guargum-based colon-targeted oral drug delivery systems of celecoxib in human volunteers.

Authors:  Y S R Krishnaiah; V Satyanarayana; B Dinesh Kumar; R S Karthikeyan; P Bhaskar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Oct-Dec       Impact factor: 2.441

2.  Pharmacokinetic evaluation of guar gum-based colon-targeted oral drug delivery systems of metronidazole in healthy volunteers.

Authors:  Y S R Krishnaiah; P Veer Raju; B Dinesh Kumar; B Jayaram; B Rama; V Raju; P Bhaskar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Oct-Dec       Impact factor: 2.441

3.  Floating osmotic drug delivery system of ranitidine hydrochloride: development and evaluation--a technical note.

Authors:  Pramod Kumar; Sanjay Singh; Brahmeshwar Mishra
Journal:  AAPS PharmSciTech       Date:  2008-03-18       Impact factor: 3.246

4.  Formulation and development of di-dependent microparticulate system for colon-specific drug delivery.

Authors:  Mayur M Patel
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

5.  Hydrophilic excipients modulate the time lag of time-controlled disintegrating press-coated tablets.

Authors:  Shan-Yang Lin; Mei-Jane Li; Kung-Hsu Lin
Journal:  AAPS PharmSciTech       Date:  2004-08-16       Impact factor: 3.246

6.  Chitosan-chondroitin sulfate based matrix tablets for colon specific delivery of indomethacin.

Authors:  Jitendra R Amrutkar; Surendra G Gattani
Journal:  AAPS PharmSciTech       Date:  2009-05-21       Impact factor: 3.246

7.  In vitro controlled release of colon targeted mesalamine from compritol ATO 888 based matrix tablets using factorial design.

Authors:  J K Patel; N V Patel; S H Shah
Journal:  Res Pharm Sci       Date:  2009-07

8.  Crucial Role of PLGA Nanoparticles in Mitigating the Amiodarone-Induced Pulmonary Toxicity.

Authors:  Amira Motawea; Dalia Alsaied Moustafa Ahmed; Ahmed A El-Mansy; Noha Mohamed Saleh
Journal:  Int J Nanomedicine       Date:  2021-07-08

9.  Development and evaluation of microbial degradation dependent compression coated secnidazole tablets for colonic delivery.

Authors:  B K Sridhar; A Srinatha; B B Zaman; H Ragunandan
Journal:  Indian J Pharm Sci       Date:  2011-11       Impact factor: 0.975

10.  Formulation of indomethacin colon targeted delivery systems using polysaccharides as carriers by applying liquisolid technique.

Authors:  Kadria A Elkhodairy; Hanna A Elsaghir; Amal M Al-Subayiel
Journal:  Biomed Res Int       Date:  2014-05-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.